Cargando…

Analysis of single nucleotide polymorphisms in chronic beryllium disease

Sarcoidosis and chronic beryllium disease (CBD) are phenocopies, however the latter one has a clear trigger factor that is beryllium exposure. This study analyses single nucleotide polymorphisms (SNPs) in a large cohort for beryllium-exposed persons. SNPs were chosen for their relevance in sarcoidos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frye, Björn C., Gaede, Karoline I., Saltini, Cesare, Rossman, Milton D., Monos, Dimitri S., Rosenman, Ken D., Schuler, Christine R., Weston, Ainsley, Wegner, Ralf, Noth, Rainer, Zissel, Gernot, Schreiber, Stefan, Nothnagel, Michael, Müller-Quernheim, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051053/ https://www.ncbi.nlm.nih.gov/pubmed/33863318 http://dx.doi.org/10.1186/s12931-021-01691-2

Ejemplares similares

Chronic Beryllium Disease and Sensitization at a Beryllium Processing Facility
por: Rosenman, Kenneth, et al.
Publicado: (2005)

Beryllium Exposure Data: Rosenman et al. Respond
por: Rosenman, Kenneth, et al.
Publicado: (2006)

Identification of HLA-DRPheβ47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGluβ69
por: Amicosante, Massimo, et al.
Publicado: (2005)

Chronic beryllium disease: diagnosis and management.
por: Rossman, M D
Publicado: (1996)

Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease.
por: Snyder, James A, et al.
Publicado: (2003)

Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) – protocol for a multi-center, single-arm phase IIa trial
por: Frye, Björn C., et al.
Publicado: (2020)

Side‐On Bonded Beryllium Dinitrogen Complexes
por: Deng, Guohai, et al.
Publicado: (2020)

High Specific Stiffness Beryllium and Beryllium Alloys
por: Levoy, N F, et al.
Publicado: (1994)

Serum Level of CC-Chemokine Ligand 18 Is Increased in Patients with Non-Small-Cell Lung Cancer and Correlates with Survival Time in Adenocarcinomas
por: Plönes, Till, et al.
Publicado: (2012)

CC-Chemokine Ligand 18 Induces Epithelial to Mesenchymal Transition in Lung Cancer A549 Cells and Elevates the Invasive Potential
por: Ploenes, Till, et al.
Publicado: (2013)

Lung Collagens Perpetuate Pulmonary Fibrosis via CD204 and M2 Macrophage Activation
por: Stahl, Mirjam, et al.
Publicado: (2013)

The natural history of beryllium sensitization and chronic beryllium disease.
por: Newman, L S, et al.
Publicado: (1996)

CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II
por: Pechkovsky, Dmitri V, et al.
Publicado: (2005)

Roflumilast-N-oxide Induces Surfactant Protein Expression in Human Alveolar Epithelial Cells Type II
por: Höhne, Kerstin, et al.
Publicado: (2012)

Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2015)

The carcinogenicity of beryllium.
por: Kuschner, M
Publicado: (1981)

The metal beryllium
por: White, Donald Wilmot
Publicado: (1955)

Beryllium metallicum
por: Stahl, Georges, et al.
Publicado: (2020)

Progression from Beryllium Exposure to Chronic Beryllium Disease: An Analytic Model
por: Harber, Philip, et al.
Publicado: (2009)

Beryllium chemistry and processing /
por: Walsh, Kenneth A.
Publicado: (2009)

Beryllium chemistry and processing
por: Walsh, Kenneth A
Publicado: (2009)

Beryllium Atom Mediated Dinitrogen Activation via Coupling with Carbon Monoxide
por: Deng, Guohai, et al.
Publicado: (2020)

Rocky Flats Beryllium Health Surveillance.
por: Stange, A W, et al.
Publicado: (1996)

Chronic beryllium disease and cancer risk estimates with uncertainty for beryllium released to the air from the Rocky Flats Plant.
por: McGavran, P D, et al.
Publicado: (1999)

Identification of beryllium-dependent peptides recognized by CD4(+) T cells in chronic beryllium disease
por: Falta, Michael T., et al.
Publicado: (2013)

Deuterium implantation in actively cooled beryllium monoblocks
por: Falter, H D, et al.
Publicado: (1997)

ALICE central beryllium chamber
por: Hertzog, Samuel Joseph
Publicado: (2019)

Beryllium Bone Sarcomata in Rabbits
por: Barnes, J. M., et al.
Publicado: (1950)

Toxic beryllium and genetic testing.
por: Danneskiold, J
Publicado: (2001)

Evaluating Beryllium Exposure Data
por: Kolanz, Marc
Publicado: (2006)

Beryllium: A Chronic Problem.
por: Lang, L
Publicado: (1994)

Heat of Formation of Beryllium Chloride
por: Johnson, Walter H., et al.
Publicado: (1961)

Beryllium‐Induced Conversion of Aldehydes
por: Müller, Matthias, et al.
Publicado: (2019)

Prevention of M2 polarization and temporal limitation of differentiation in monocytes by extracellular ATP
por: Scherr, Benedikt F., et al.
Publicado: (2023)

Beryllium Increases the CD14(dim)CD16+ Subset in the Lung of Chronic Beryllium Disease
por: Li, Li, et al.
Publicado: (2015)

Chronic Beryllium Disease: Revealing the Role of Beryllium Ion and Small Peptides Binding to HLA-DP2
por: Petukh, Marharyta, et al.
Publicado: (2014)

Animal models of beryllium-induced lung disease.
por: Finch, G L, et al.
Publicado: (1996)

Beryllium induced sarcomas of the rabbit tibia.
por: Tapp, E.
Publicado: (1966)

Introduction to the conference on beryllium-related diseases.
por: Jameson, C W
Publicado: (1996)

The uses and adverse effects of beryllium on health
por: Cooper, Ross G., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_5tq0midnmp6vlpoobiou5c9jmj